SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PACIARONI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.869
NA - Nord America 1.626
EU - Europa 1.473
SA - Sud America 960
AF - Africa 113
OC - Oceania 28
Totale 7.069
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.475
SG - Singapore 1.208
BR - Brasile 791
HK - Hong Kong 593
CN - Cina 383
VN - Vietnam 330
NL - Olanda 306
IT - Italia 287
DE - Germania 147
GB - Regno Unito 110
FR - Francia 92
CA - Canada 88
RU - Federazione Russa 76
AR - Argentina 61
UA - Ucraina 57
EC - Ecuador 56
ZA - Sudafrica 52
BE - Belgio 51
ES - Italia 50
JP - Giappone 49
AE - Emirati Arabi Uniti 46
AT - Austria 44
MX - Messico 44
BD - Bangladesh 41
IN - India 39
PT - Portogallo 39
PL - Polonia 38
FI - Finlandia 37
ID - Indonesia 37
HU - Ungheria 30
EG - Egitto 28
SE - Svezia 28
TW - Taiwan 28
AU - Australia 27
IE - Irlanda 23
TR - Turchia 21
IQ - Iraq 16
PY - Paraguay 14
NO - Norvegia 12
CO - Colombia 11
MA - Marocco 11
UZ - Uzbekistan 11
LT - Lituania 9
PK - Pakistan 9
CH - Svizzera 8
IL - Israele 8
PE - Perù 8
CL - Cile 7
DZ - Algeria 6
KE - Kenya 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
JM - Giamaica 5
MY - Malesia 5
OM - Oman 5
TN - Tunisia 5
BO - Bolivia 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HR - Croazia 4
KZ - Kazakistan 4
TH - Thailandia 4
UY - Uruguay 4
VE - Venezuela 4
AM - Armenia 3
CR - Costa Rica 3
JO - Giordania 3
RO - Romania 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
GE - Georgia 2
GR - Grecia 2
IR - Iran 2
LV - Lettonia 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
HN - Honduras 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
NC - Nuova Caledonia 1
PH - Filippine 1
PS - Palestinian Territory 1
Totale 7.069
Salva come PNG Salva come JPEG
Città #
Hong Kong 590
Singapore 493
Ashburn 291
Dallas 155
Beijing 151
Ho Chi Minh City 114
Hanoi 91
Los Angeles 87
Amsterdam 84
São Paulo 65
Utrecht 53
Chicago 48
Hefei 48
New York 46
Tokyo 42
Groningen 38
Abu Dhabi 37
Lisbon 37
Quito 36
Warsaw 36
Bologna 35
Budapest 28
Mulhouse 28
Nuremberg 28
Poplar 27
De Lier 26
Barcelona 25
Mexico City 25
Lappeenranta 24
Stockholm 24
Cairo 23
Taichung 22
Belo Horizonte 21
Paris 21
Vancouver 21
Dublin 20
Rio de Janeiro 20
Boardman 19
Brooklyn 19
Denver 19
Santa Clara 19
Falkenstein 18
Milan 18
Salt Lake City 18
Atlanta 17
Naaldwijk 17
Des Moines 16
Ferrara 16
Sydney 16
Curitiba 15
Montreal 15
Dhaka 14
Haiphong 14
Jakarta 14
Orem 14
Brasília 13
Guarulhos 13
Munich 13
Shanghai 13
Tampa 13
Winschoten 13
Woodbridge 13
Boston 12
Da Nang 12
Guayaquil 12
Moscow 12
Seattle 12
Frankfurt am Main 11
Porto Alegre 11
Rome 11
Biên Hòa 10
Derby 10
Fairfield 10
Johannesburg 10
London 10
Madrid 10
Rotterdam 10
Tashkent 10
Toronto 10
Vienna 10
Winnipeg 10
Bari 9
Cambridge 9
Chennai 9
Florence 9
Hangzhou 9
Houston 9
Hải Dương 9
Phoenix 9
Salvador 9
Assago 8
Etobicoke 8
Melbourne 8
Ninh Bình 8
Oslo 8
Panningen 8
San Francisco 8
Campinas 7
Cape Town 7
Jacksonville 7
Totale 3.710
Salva come PNG Salva come JPEG
Nome #
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 908
Association Between Migraine and Cervical Artery Dissection The Italian Project on Stroke in Young Adults 112
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 89
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 87
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 86
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: The MUCH Italy 77
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 74
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 72
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging – Results from the READAPT study 69
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage 65
Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy 62
History of stroke 59
Age- and sex-specific analysis of patients with embolic stroke of undetermined source 58
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 58
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models 57
Treatments in Ischemic Stroke: Current and Future 57
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 57
Long-term outcome of cervical artery dissection : IPSYS CeAD: study protocol, rationale, and baseline data of an Italian multicenter research collaboration 57
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial 55
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome 54
Risk Profile of Patients with Spontaneous Cervical Artery Dissection 53
The turning point in stroke investigation for neurologists 52
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 52
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant dta meta-analysis 51
15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry 50
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 49
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis 49
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation 48
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection 48
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 48
Consensus paper on the management of acute isolated vertigo in the emergency department 48
Anticoagulation After Stroke in Patients With Atrial Fibrillation 48
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke 48
Migraine improvement after spontaneous cervical artery dissection the Italian Project on Stroke in Young Adults (IPSYS) 47
History of cardiac embolism 47
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 46
Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia 46
Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study 46
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome 45
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke 45
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack 45
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both? 45
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013] 45
Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention? 44
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin 44
A sudden neurological deficit in a patient with endocarditis 44
Predictors of severe intracerebral hemorrhage expansion 44
Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies 44
Erratum to: Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO Study (Neurol Sci (2014) 35, (867-873), 10.1007/s10072-013-1615-2) 44
Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score 43
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 43
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 43
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 43
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 43
A case of typical headache with an atypical diagnosis 43
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 42
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 42
How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group 42
Migraine and Cryptogenic Ischemic Stroke 41
Profilassi secondaria nel paziente con attacco ischemico transitorio o ictus aterotrombotico carotideo [Secondary prevention in patients with transient ischemic attack or stroke due to carotid atherosclerosis] 41
The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS) 41
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion 41
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT Study 40
A tool to identify patients with embolic stroke of undetermined source at high recurrence risk 40
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 40
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 40
Acute hematoma expansion after spontaneous intracerebral hemorrhage: risk factors and impact on long-term prognosis 40
Characteristics of intracerebral hemorrhage associated with dual antiplatelet treatment 40
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 40
Medical versus neurosurgical treatment in ICH patients: a single center experience 39
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 39
Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis: Analysis of the ACTION CVT 38
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 38
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study 38
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 38
Secondary stroke prevention in people with atrial fibrillation: treatments and trials 38
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study 38
Long-Term Risk of Recurrent Cervical Artery Dissection and Stroke After Pregnancy 38
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis 37
Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis 37
Comparative study of venous thromboembolic prophylaxis strategies in hemorrhagic stroke: A systematic review and network meta-analysis 37
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials 37
Acute stroke treatment: thrombolysis 37
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 36
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation 36
Acute stroke symptoms: Do differences exist between sexes? 34
Susceptibility to brain ischemia and the association between migraine and spontaneous cervical artery dissection 34
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial 34
Systemic thrombolysis in patients with acute stroke and active cancer: a systematic review and meta-analysis 34
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 34
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 34
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 31
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 30
Un caffè tra due amici al bar. L'esame obiettivo neurologico 30
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 30
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 30
Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke 29
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 29
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 28
Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy 28
Totale 5.476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.605
Totale 38.692
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 3 0 7 3 9 3 2
2021/202218 2 1 0 5 1 0 3 0 0 0 2 4
2022/20238 2 1 0 0 0 0 1 0 1 2 0 1
2023/20246 1 0 0 0 1 0 0 0 0 0 0 4
2024/20252.068 0 0 4 0 2 78 395 315 224 524 271 255
2025/20265.412 571 675 1.161 1.559 1.337 109 0 0 0 0 0 0
Totale 7.577